EA201492250A1 - Гетероциклическое соединение - Google Patents
Гетероциклическое соединениеInfo
- Publication number
- EA201492250A1 EA201492250A1 EA201492250A EA201492250A EA201492250A1 EA 201492250 A1 EA201492250 A1 EA 201492250A1 EA 201492250 A EA201492250 A EA 201492250A EA 201492250 A EA201492250 A EA 201492250A EA 201492250 A1 EA201492250 A1 EA 201492250A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salt
- autoimmune diseases
- present
- disease
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Настоящее изобретение предлагает соединение или его соль, обладающее исключительным ингибирующим действием в отношении янус-киназы (JAK), которое применяют в качестве лекарственного средства для профилактики или лечения аутоиммунных заболеваний (ревматоидного артрита, псориаза, воспалительного заболевания кишечника, синдрома Шегрена, болезни Бехчета, множественного склероза, системной эритематозной волчанки и других аутоиммунных заболеваний), рака (лейкоза, лейомиосаркомы матки, рака предстательной железы, множественной миеломы, кахексии, миелофиброза и других раковых заболеваний) и других подобных заболеваний. Настоящее изобретение относится к соединению, представленному формулойгде каждый символ определен в описании изобретения, или к его соли.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012126462 | 2012-06-01 | ||
PCT/JP2013/065183 WO2013180265A1 (ja) | 2012-06-01 | 2013-05-31 | 複素環化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201492250A1 true EA201492250A1 (ru) | 2015-08-31 |
Family
ID=49673448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201492250A EA201492250A1 (ru) | 2012-06-01 | 2013-05-31 | Гетероциклическое соединение |
Country Status (8)
Country | Link |
---|---|
US (2) | US9371320B2 (ru) |
EP (1) | EP2857400A4 (ru) |
JP (1) | JPWO2013180265A1 (ru) |
CN (1) | CN104507940B (ru) |
BR (1) | BR112014029705A2 (ru) |
CA (1) | CA2874987A1 (ru) |
EA (1) | EA201492250A1 (ru) |
WO (1) | WO2013180265A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105189508B (zh) * | 2013-03-19 | 2018-11-23 | 默沙东公司 | 作为janus激酶抑制剂的环烷基腈吡唑并吡啶酮 |
JP6305510B2 (ja) * | 2013-03-19 | 2018-04-04 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | ヤヌスキナーゼ阻害剤としての非環式シアノエチルピラゾロピリドン |
WO2014146246A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
BR112015023878A2 (pt) * | 2013-03-19 | 2017-07-18 | Merck Sharp & Dohme | composto, composição farmacêutica, e, uso de um composto |
WO2014146249A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors |
ES2661012T3 (es) * | 2013-03-28 | 2018-03-27 | Takeda Pharmaceutical Company Limited | Compuesto heterocíclico |
WO2019073253A1 (en) | 2017-10-13 | 2019-04-18 | Imperial Innovations Limited | INHIBITORS OF MAP4K4 |
KR102094802B1 (ko) * | 2017-10-24 | 2020-03-31 | 고려대학교 산학협력단 | 소변 대사체 분석을 이용한 베체트병의 진단방법 |
CN110343103A (zh) * | 2019-07-04 | 2019-10-18 | 深圳市格物致欣化学技术有限公司 | 吡唑并吡啶类化合物及其制备方法 |
BR112023016590A2 (pt) | 2021-02-19 | 2023-11-14 | Sudo Biosciences Ltd | Inibidores de tyk2 e seus usos |
CN113671064B (zh) * | 2021-07-15 | 2022-05-17 | 中国海洋大学 | 一种定量分析血浆中氨来占诺的血药浓度的检测方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663559A (en) | 1969-12-03 | 1972-05-16 | Union Carbide Corp | Preparation of oxo-furo-pyridines from furylvinyl isocyanates |
JPS5814437B2 (ja) * | 1975-12-25 | 1983-03-18 | タイホウヤクヒンコウギヨウ カブシキガイシヤ | ピラゾロピリジン −3− カルボンサンユウドウタイノセイゾウホウ |
JPS5814438B2 (ja) * | 1975-12-27 | 1983-03-18 | タイホウヤクヒンコウギヨウ カブシキガイシヤ | ピラゾロピリジンユウドウタイノ セイゾウホウホウ |
JP2759227B2 (ja) | 1990-09-28 | 1998-05-28 | 大鵬薬品工業株式会社 | ピラゾロピリジン誘導体 |
US7049312B1 (en) | 1999-06-03 | 2006-05-23 | Abbott Gmbh & Co. Kg | Benzothiazinone and benzoxazinone compounds |
AU2003241925A1 (en) | 2002-05-31 | 2003-12-19 | Eisai R&D Management Co., Ltd. | Pyrazole compound and medicinal composition containing the same |
UY28103A1 (es) * | 2002-12-03 | 2004-06-30 | Boehringer Ingelheim Pharma | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos |
AR045595A1 (es) | 2003-09-04 | 2005-11-02 | Vertex Pharma | Composiciones utiles como inhibidores de proteinas quinasas |
WO2006003440A1 (en) * | 2004-07-05 | 2006-01-12 | Astex Therapeutics Limited | 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
US7868000B2 (en) | 2005-06-14 | 2011-01-11 | Schering Corporation | Aspartyl protease inhibitors |
US7807704B2 (en) | 2006-03-30 | 2010-10-05 | Chemocentryx, Inc. | Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 |
EP2108642A1 (en) | 2006-10-17 | 2009-10-14 | Kyowa Hakko Kirin Co., Ltd. | Jak inhibitor |
KR20090097908A (ko) | 2006-12-06 | 2009-09-16 | 베링거 인겔하임 인터내셔날 게엠베하 | 글루코코르티코이드 모사물, 이의 제조 방법, 이의 약제학적 조성물 및 용도 |
AR077033A1 (es) | 2009-06-11 | 2011-07-27 | Hoffmann La Roche | Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas |
EP2611809A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Azolopyridine and azolopyrimidine compounds and methods of use thereof |
EP2818473A4 (en) | 2012-02-20 | 2015-04-15 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUND |
WO2014146246A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
-
2013
- 2013-05-31 CA CA2874987A patent/CA2874987A1/en not_active Abandoned
- 2013-05-31 BR BR112014029705A patent/BR112014029705A2/pt not_active IP Right Cessation
- 2013-05-31 WO PCT/JP2013/065183 patent/WO2013180265A1/ja active Application Filing
- 2013-05-31 EP EP13797604.9A patent/EP2857400A4/en not_active Withdrawn
- 2013-05-31 EA EA201492250A patent/EA201492250A1/ru unknown
- 2013-05-31 CN CN201380040684.1A patent/CN104507940B/zh not_active Expired - Fee Related
- 2013-05-31 JP JP2014518750A patent/JPWO2013180265A1/ja not_active Withdrawn
- 2013-05-31 US US14/404,126 patent/US9371320B2/en not_active Expired - Fee Related
-
2016
- 2016-05-06 US US15/148,276 patent/US20160251352A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2857400A4 (en) | 2015-12-09 |
WO2013180265A1 (ja) | 2013-12-05 |
US20150141406A1 (en) | 2015-05-21 |
BR112014029705A2 (pt) | 2017-06-27 |
US9371320B2 (en) | 2016-06-21 |
EP2857400A1 (en) | 2015-04-08 |
US20160251352A1 (en) | 2016-09-01 |
JPWO2013180265A1 (ja) | 2016-01-21 |
CN104507940A (zh) | 2015-04-08 |
CA2874987A1 (en) | 2013-12-05 |
CN104507940B (zh) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201492250A1 (ru) | Гетероциклическое соединение | |
EA201591881A1 (ru) | Гетероциклическое соединение | |
PH12018502125A1 (en) | Bipyrazole derivatives as jak inhibitors | |
EA201890338A1 (ru) | Оксадиазольные производные, пригодные в качестве ингибиторов hdac | |
PH12018501268A1 (en) | Compounds useful as kinase inhibitors | |
MX2017000331A (es) | Compuestos de aminopiridazinona como inhibidores de quinasas de proteina. | |
IN2012CH01573A (ru) | ||
EA201590281A1 (ru) | Новые гетероарильные и гетероциклические соединения, их композиции и способы | |
EA201590850A1 (ru) | Трициклические конденсированные производные тиофена как ингибиторы jak | |
PE20160995A1 (es) | Inhibidores de syk | |
EA201591296A1 (ru) | Фталазиноны и изохинолиноны в качестве ингибиторов rock | |
EA201690094A1 (ru) | Ингибиторы syk | |
EA201592024A1 (ru) | Замещенные 5-(3,5-диметилизоксазол-4-ил)-индолин-2-оны | |
EA201290305A1 (ru) | Производные трициклического пиразоламина | |
EA201591753A1 (ru) | 3-пиримидин-4-илоксазолидин-2-оны в качестве ингибиторов мутантного idh | |
WO2014093230A3 (en) | Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity | |
EA201592033A1 (ru) | 3-(2-АМИНОПИРИМИДИН-4-ИЛ)-5-(3-ГИДРОКСИПРОПИНИЛ)-1H-ПИРРОЛО[2,3-c]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ NIK ДЛЯ ЛЕЧЕНИЯ РАКА | |
PH12020551390A1 (en) | AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS | |
EA201700042A1 (ru) | Соединения имидазопиридазина | |
EA201790206A1 (ru) | Новые 2,5-замещенные пиримидины в качестве ингибиторов pde4 | |
EA201600636A1 (ru) | 2-амино-6-метил-4,4а,5,6-тетрагидропирано[3,4-d][1,3]тиазин-8а(8н)-ил-1,3-тиазол-4-ил амиды | |
EA201890524A1 (ru) | (s,e)-3-(6-аминопиридин-3-ил)-n-((5-(4-(3-фтор-3-метилпирролидин-1-карбонил)фенил)-7-(4-фторфенил)бензофуран-2-ил)метил)акриламид для лечения рака | |
MX2015010466A (es) | Inhibidores de tirosina cinasa de bruton. | |
MX2015010983A (es) | Inhibidores de tirosina-cinasa de bruton. | |
EA201790209A1 (ru) | Новые 2,5-замещенные пиримидины в качестве ингибиторов pde |